These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 21066991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn's disease: A cohort study from northern India.
    Singh A, Kakkar C, Garg S, Arora K, Midha V, Mahajan R, Virk SS, Jain NP, Singh D, Sood K, Tripathi A, Gupta D, Kaushal IG, Galhotra RD, Saggar K, Sood A.
    Indian J Gastroenterol; 2023 Oct; 42(5):668-676. PubMed ID: 37548863
    [Abstract] [Full Text] [Related]

  • 3. Combined modality treatment for complex fistulating perianal Crohn's disease.
    Antakia R, Shorthouse AJ, Robinson K, Lobo AJ.
    Colorectal Dis; 2013 Feb; 15(2):210-6. PubMed ID: 22672653
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure.
    Echarri A, Castro J, Barreiro M, Carpio D, Pereira S, Lorenzo A.
    J Crohns Colitis; 2010 Dec; 4(6):654-60. PubMed ID: 21122576
    [Abstract] [Full Text] [Related]

  • 5. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M, Pakarinen MP, Piekkala M, Koivusalo A, Rintala R, Kolho KL.
    J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
    [Abstract] [Full Text] [Related]

  • 6. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
    Regueiro M, Mardini H.
    Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443
    [Abstract] [Full Text] [Related]

  • 7. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
    Schwartz DA, White CM, Wise PE, Herline AJ.
    Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD.
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease.
    Davidov Y, Ungar B, Bar-Yoseph H, Carter D, Haj-Natour O, Yavzori M, Chowers Y, Eliakim R, Ben-Horin S, Kopylov U.
    J Crohns Colitis; 2017 May 01; 11(5):549-555. PubMed ID: 28453755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.